Bank of New York Mellon

Bank of New York Mellon’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bank of New York Mellon’s Portfolio TLIS Stock Details TLIS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$74K	Sell
2021 Q4	$219K	Sell
2021 Q3	$550K	Buy
2021 Q2	$938K	Buy
2021 Q1	$1.03M	Buy